Skip to content

745 Glycomat

by Drew Scientific, Ltd.

510(k) K933287

745 Glycomat is a medical device (FDA Class II; FDA product code LCP, Assay, Glycosylated Hemoglobin) made by Drew Scientific, Ltd., cleared under FDA 510(k) K933287 on 9 Sep 1993, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK933287 Date9 Sep 1993ClearedStatusActive

Official records

From the FDA record

Received by the FDA
6 Jul 1993
FDA decision
9 Sep 1993 (Substantially Equivalent)
FDA review time
65 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K933287 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LCP
FDA applicant
Drew Scientific , Ltd.
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Devices cleared under K933287

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K933287
UDI-DISize and differences
Drew Scientific 014-350
Drew Scientific, Ltd.
014-35000817274020173 —On the market

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from Drew Scientific, Ltd.

See all devices from Drew Scientific, Ltd. →